Position
Chief Executive Officer
Company
Elevar Therapeutics and Relay Therapeutics
Description
Elevar Therapeutics has appointed Kim Dong-gun as the new chief executive officer following the submission of a New Drug Application for cancer drug candidates. His extensive experience is expected to enhance the company's focus on regulatory review and post-approval commercialization.
Quick answer
Elevar Therapeutics Appoints Kim Dong-gun as Chief Executive Officer (January 29, 2026).
- Who is the new Chief Executive Officer at Elevar Therapeutics and Relay Therapeutics?
- Elevar Therapeutics and Relay Therapeutics named Kim Dong-gun Chief Executive Officer, announced January 29, 2026.
- What did Elevar Therapeutics and Relay Therapeutics announce on January 29, 2026?
- Elevar Therapeutics has appointed Kim Dong-gun as the new chief executive officer following the submission of a New Drug Application for cancer drug candidates. His extensive experience is expected to enhance the company's focus on regulatory review and post-approval commercialization.
- What does Elevar Therapeutics and Relay Therapeutics do?
- Elevar Therapeutics is a fully integrated biopharmaceutical company dedicated to elevating treatment outcomes for patients who have limited or inadequate therapeutic options.
- Which similar companies made leadership changes around the same time?
- Bristol Myers Squibb (February 9, 2026), Oculis Holding AG (February 17, 2026), Aquestive Therapeutics, Inc. (February 18, 2026) and Mezzion Pharma (January 6, 2026) also announced leadership changes within 45 days of Elevar Therapeutics and Relay Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biopharma
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Bristol Myers Squibb Appoints Harald Hampel as Senior VP Worldwide Head of Medical Affairs. (February 9, 2026)
- Oculis Holding AG Appoints Katie Kazem as Chief Legal Officer (February 17, 2026)
- Aquestive Therapeutics Appoints Dr. Matthew Greenhawt as Chief Medical Officer (February 18, 2026)
- Mezzion Pharmaceuticals Appoints Ridwan Shabsigh as President and COO (January 6, 2026)
- Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia (March 3, 2026)
- XyloCor Appoints John Tucker as Chief Executive Officer (March 5, 2026)
Who to call at Elevar Therapeutics and Relay Therapeutics, and when
A new leader at Elevar Therapeutics and Relay Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Elevar Therapeutics and Relay Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Elevar Therapeutics and Relay Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Elevar Therapeutics and Relay Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Elevar Therapeutics and Relay Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Elevar Therapeutics and Relay Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.